De Castro, L. M., Wun, T., Lanzkron, S., Smith, W. R., Hassell, K. L., Kutlar, A., … Thackray, H. (2013). Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease. In Blood (Vol. 122, pp. 775–775). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.775.775

De Castro, Laura M., Ted Wun, Sophie Lanzkron, Wally R. Smith, Kathryn L. Hassell, Abdullah Kutlar, Kim Smith-Whitley, Seungshin Rhee, Marilyn J. Telen, and Helen Thackray. “Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease.” In Blood, 122:775–775. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.775.775.

De Castro LM, Wun T, Lanzkron S, Smith WR, Hassell KL, Kutlar A, et al. Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease. In: Blood. American Society of Hematology; 2013. p. 775–775.

De Castro, Laura M., et al. “Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 775–775. Crossref, doi:10.1182/blood.v122.21.775.775.

De Castro LM, Wun T, Lanzkron S, Smith WR, Hassell KL, Kutlar A, Smith-Whitley K, Rhee S, Telen MJ, Thackray H. Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease. Blood. American Society of Hematology; 2013. p. 775–775.